BIOVENTUS INC - A (BVS) Forecast, Price Target & Analyst Ratings

NASDAQ:BVSUS09075A1088

Current stock price

8.64 USD
-0.36 (-4%)
At close:
8.64 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIOVENTUS INC - A (BVS).

Forecast Snapshot

Consensus Price Target

Price Target
$14.79
+ 71.18% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
$0.10
Revenue Estimate
131.6M

ChartMill Buy Consensus

Rating
82.50%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$14.79
Upside
+ 71.18%
From current price of $8.64 to mean target of $14.79, Based on 8 analyst forecasts
Low
$13.13
Median
$15.30
High
$15.75

Price Target Revisions

1 Month
-3.33%
3 Months
-3.33%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for BVS. The average price target is 14.79 USD. This implies a price increase of 71.18% is expected in the next year compared to the current price of 8.64.
The average price target has been revised downward by 3.33% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

BVS Current Analyst RatingBVS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

BVS Historical Analyst RatingsBVS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.50%
BVS was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about BVS.
In the previous month the buy percentage consensus was at a similar level.
BVS was analyzed by 8 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-06Barrington ResearchMaintains Outperform -> Outperform
2026-03-06Craig-HallumMaintains Buy -> Buy
2026-02-09Barrington ResearchInitiate Outperform
2025-07-07Cantor FitzgeraldInitiate Overweight
2025-03-17Canaccord GenuityMaintains Buy -> Buy
2024-12-17JP MorganUpgrade Underweight -> Neutral
2024-11-06Canaccord GenuityMaintains Buy -> Buy
2024-09-27Craig-HallumMaintains Buy -> Buy
2024-08-13Canaccord GenuityMaintains Buy -> Buy
2024-08-07Craig-HallumMaintains Buy -> Buy
2024-05-08Canaccord GenuityMaintains Buy -> Buy
2024-03-13Craig-HallumMaintains Buy -> Buy
2023-12-07Canaccord GenuityUpgrade Hold -> Buy
2023-04-03Craig-HallumMaintains Hold
2022-11-30Goldman SachsMaintains Neutral
2022-11-22Craig-HallumDowngrade Buy -> Hold
2022-11-10Morgan StanleyMaintains Overweight
2022-11-09JP MorganDowngrade Overweight -> Underweight
2022-11-09Canaccord GenuityDowngrade Buy -> Hold
2022-10-11Morgan StanleyMaintains Overweight
2022-09-07Goldman SachsMaintains Neutral
2022-08-12Morgan StanleyMaintains Overweight
2022-05-12Morgan StanleyMaintains Overweight
2022-03-11Morgan StanleyMaintains Overweight
2021-11-15Morgan StanleyReiterate Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
$0.10
Revenue Estimate
131.6M
Revenue Q2Q
6.24%
EPS Q2Q
30.45%
Number of Analysts
5

Next Earnings Revisions

Revenue (1 Month)
-1.59%
Revenue (3 Months)
-1.59%
EPS (1 Month)
-13.89%
EPS (3 Months)
-17.34%

Next Earnings Summary

BVS is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is 0.1 USD and the consensus revenue estimate is 131.60M USD.
The next earnings revenue estimate has been revised downward by 1.59% in the past 3 months.

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
BVS revenue by date.BVS revenue by date.
512.345M
0.05%
573.28M
11.89%
568.087M
-0.91%
610.31M
7.43%
650.65M
6.61%
694.1M
6.68%
737.07M
6.19%
792.93M
7.58%
EBITDA
YoY % growth
BVS ebitda by date.BVS ebitda by date.
58.672M
397.22%
70.957M
20.94%
103.302M
45.58%
119.45M
15.63%
133.79M
12.01%
N/A156.31M177.09M
13.29%
EBIT
YoY % growth
BVS ebit by date.BVS ebit by date.
1.307M
102.38%
21.402M
1,537.49%
56.291M
163.02%
93.554M
66.20%
105.34M
12.60%
109.77M
4.21%
N/AN/A
Operating Margin
BVS operating margin by date.BVS operating margin by date.
0.26%3.73%9.91%15.33%16.19%15.81%N/AN/A
EPS
YoY % growth
BVS eps by date.BVS eps by date.
0.00
-100.00%
0.470.68
44.68%
0.78
14.86%
0.89
13.36%
N/A1.051.21
15.38%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
0.10
30.45%
0.23
10.62%
0.20
31.30%
0.25
3.10%
0.14
35.49%
0.28
21.74%
0.20
2.56%
0.30
22.45%
Revenue
Q2Q % growth
131.6M
6.24%
160.11M
8.43%
149.56M
7.87%
169.83M
7.56%
141.1M
7.22%
169.07M
5.60%
157.26M
5.15%
176.65M
4.02%
EBITDA
Q2Q % growth
22.023M
30.97%
32.846M
-22.32%
30.98M
-33.47%
36.589M
-46.77%
25.048M
13.74%
38.683M
17.77%
30.805M
-0.56%
40.4M
10.42%
EBIT
Q2Q % growth
14.893M
200.87%
28.462M
54.95%
28.919M
157.03%
33.324M
53.42%
22.018M
47.84%
35.653M
25.27%
27.775M
-3.96%
37.37M
12.14%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

BVS Yearly Revenue VS EstimatesBVS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
BVS Yearly EPS VS EstimatesBVS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2029 2030 0 0.5 1 1.5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
12.25%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
6.70%
Revenue Next 5 Year
6.77%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
17.26%

BIOVENTUS INC - A / BVS Forecast FAQ

Can you provide the average price target for BIOVENTUS INC - A stock?

8 analysts have analysed BVS and the average price target is 14.79 USD. This implies a price increase of 71.18% is expected in the next year compared to the current price of 8.64.

What is the next earnings date for BVS stock?

BIOVENTUS INC - A (BVS) will report earnings on 2026-05-04.

Can you provide the consensus estimates for BIOVENTUS INC - A next earnings?

The consensus EPS estimate for the next earnings of BIOVENTUS INC - A (BVS) is 0.1 USD and the consensus revenue estimate is 131.60M USD.

Can you provide the analyst count for BIOVENTUS INC - A stock?

The number of analysts covering BIOVENTUS INC - A (BVS) is 8.